Cargando…

Monitoring the Intracellular Tacrolimus Concentration in Kidney Transplant Recipients with Stable Graft Function

Although monitoring the intracellular concentration of immunosuppressive agents may be a promising approach to individualizing the therapy after organ transplantation, additional studies on this issue are needed prior to its clinical approval. We investigated the relationship between intracellular a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Seung Seok, Yang, Seung Hee, Kim, Min Chang, Cho, Joo-Youn, Min, Sang-Il, Lee, Jung Pyo, Kim, Dong Ki, Ha, Jongwon, Kim, Yon Su
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833335/ https://www.ncbi.nlm.nih.gov/pubmed/27082871 http://dx.doi.org/10.1371/journal.pone.0153491

Ejemplares similares

Association between medication adherence and intrapatient variability in tacrolimus concentration among stable kidney transplant recipients
por: Ko, Hyunmin, et al.
Publicado: (2021)

Risk of Graft Failure in Kidney Recipients with Cured Post-Transplant Cancer
por: Kim, Ji Eun, et al.
Publicado: (2020)

Pharmacokinetics of tacrolimus according to body composition in recipients of kidney transplants
por: Han, Seung Seok, et al.
Publicado: (2012)

Flat Pattern Peaks of Tacrolimus Absorption and Associated Pharmacogenomic Variants in Kidney Transplantation Recipients
por: Kim, Suh Min, et al.
Publicado: (2022)

Association of Intrapatient Variability of Tacrolimus Concentration With Early Deterioration of Chronic Histologic Lesions in Kidney Transplantation
por: Mo, Hyejin, et al.
Publicado: (2019)

Deep Learning-Based Quantification of Visceral Fat Volumes Predicts Posttransplant Diabetes Mellitus in Kidney Transplant Recipients
por: Kim, Ji Eun, et al.
Publicado: (2021)

Association of high intra-patient variability in tacrolimus exposure with calcineurin inhibitor nephrotoxicity in kidney transplantation
por: Kim, Hyokee, et al.
Publicado: (2023)

Whole exome sequencing for the identification of CYP3A7 variants associated with tacrolimus concentrations in kidney transplant patients
por: Sohn, Minji, et al.
Publicado: (2018)

Author Correction: Whole exome sequencing for the identification of CYP3A7 variants associated with tacrolimus concentrations in kidney transplant patients
por: Sohn, Minji, et al.
Publicado: (2020)

Ratio of triglyceride to high-density lipoprotein cholesterol and risk of major cardiovascular events in kidney transplant recipients
por: Kim, Ji Eun, et al.
Publicado: (2019)

Serum Bilirubin Affects Graft Outcomes through UDP-Glucuronosyltransferase Sequence Variation in Kidney Transplantation
por: Lee, Jung Pyo, et al.
Publicado: (2014)

Mobile medication manager application to improve adherence with immunosuppressive therapy in renal transplant recipients: A randomized controlled trial
por: Han, Ahram, et al.
Publicado: (2019)

Effect of the similarity of gut microbiota composition between donor and recipient on graft function after living donor kidney transplantation
por: Kim, Ji Eun, et al.
Publicado: (2020)

Tacrolimus trough levels in kidney transplant recipients
por: Hwang, Young Hui, et al.
Publicado: (2021)

Long-Term Safety and Efficacy of Tacrolimus in Myasthenia Gravis
por: Kim, Yool-hee, et al.
Publicado: (2019)

Tacrolimus trough levels higher than 6 ng/mL might not be required after a year in stable kidney transplant recipients
por: Jung, Hee-Yeon, et al.
Publicado: (2020)

Systematic conversion to generic tacrolimus in stable kidney transplant recipients
por: Rosenborg, Staffan, et al.
Publicado: (2014)

Comparison of the long-term efficacy and safety of generic Tacrobell with original tacrolimus (Prograf) in kidney transplant recipients
por: Son, Seung Yeon, et al.
Publicado: (2017)

Kidney Transplantation in Sensitized Recipients; A Single Center Experience
por: Kim, Sun Moon, et al.
Publicado: (2009)

Monitoring the tacrolimus concentration in peripheral blood mononuclear cells of kidney transplant recipients
por: Francke, Marith I., et al.
Publicado: (2020)

Model based development of tacrolimus dosing algorithm considering CYP3A5 genotypes and mycophenolate mofetil drug interaction in stable kidney transplant recipients
por: Kim, Jae Hyun, et al.
Publicado: (2019)

Immunomodulation in stable renal transplant recipients with concomitant tacrolimus and sirolimus therapy
por: Khanna, Ashwani, et al.
Publicado: (2002)

Race and sex associations with tacrolimus pharmacokinetics in stable kidney transplant recipients
por: Tornatore, Kathleen M., et al.
Publicado: (2022)

Weaning Immunosuppressant in Patients with Failing Kidney Grafts and The Outcomes: A Single-Center Retrospective Cohort Study
por: Ryu, Hyunjin, et al.
Publicado: (2020)

The Need for New Donor Stratification to Predict Graft Survival in Deceased Donor Kidney Transplantation
por: Yang, Shin-Seok, et al.
Publicado: (2017)

Posttransplant Hyponatremia Predicts Graft Failure and Mortality in Kidney Transplantation Recipients: A Multicenter Cohort Study in Korea
por: Han, Seung Seok, et al.
Publicado: (2016)

Switching Stable Kidney Transplant Recipients to a Generic Tacrolimus Is Feasible and Safe, but It Must Be Monitored
por: González, Fernando, et al.
Publicado: (2017)

Value of perioperative genitourinary screening culture and colonization status in predicting early urinary tract infection after renal transplantation
por: Han, Ahram, et al.
Publicado: (2018)

Severe anorexia and weight loss induced by tacrolimus in kidney transplant recipients
por: Hwang, Hong Pil, et al.
Publicado: (2021)

Low Transfer of Tacrolimus and Its Metabolites into Colostrum of Graft Recipient Mothers
por: Kociszewska-Najman, Bozena, et al.
Publicado: (2018)

Efficacy and safety of a switch from twice-daily tacrolimus to once-daily generic tacrolimus in stable liver transplant patients
por: Kim, Jong Man, et al.
Publicado: (2021)

A Population Pharmacokinetic Model of Whole-Blood and Intracellular Tacrolimus in Kidney Transplant Recipients
por: Franken, Linda G., et al.
Publicado: (2022)

A non-randomized trial of conversion from ciclosporin and tacrolimus to tacrolimus MR4 in stable long-term kidney transplant recipients: Graft function and influences of ABCB1 genotypes
por: Riegersperger, Markus, et al.
Publicado: (2019)

Trends in Deceased Organ Donation and Utilization in Korea: 2000-2009
por: Min, Sang Il, et al.
Publicado: (2010)

Effects of Wuzhi Capsules on Blood Concentration of Tacrolimus in Renal Transplant Recipients
por: Yan, Lin, et al.
Publicado: (2019)

Evaluation of clotrimazole prophylaxis on tacrolimus trough concentrations in kidney transplant recipients
por: Wings, Emily, et al.
Publicado: (2022)

Maculopathy Associated with Tacrolimus (FK 506)
por: Koh, Taehyuk, et al.
Publicado: (2011)

Reduced Tacrolimus Trough Level Is Reflected by Estimated Glomerular Filtration Rate (eGFR) Changes in Stable Renal Transplantation Recipients: Results of the OPTIMUM Phase 3 Randomized Controlled Study
por: Park, Sehoon, et al.
Publicado: (2018)

Population pharmacokinetics and pharmacogenetics of once daily tacrolimus formulation in stable liver transplant recipients
por: Moes, D. J. A. R, et al.
Publicado: (2015)

Application of Machine-Learning Models to Predict Tacrolimus Stable Dose in Renal Transplant Recipients
por: Tang, Jie, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_a6hco530c03ub2ckqh91lcmtmn